Table 1.
Baseline clinical characteristics
| Variable | Men, n = 77 | Women, n = 26 | P Value |
|---|---|---|---|
| Age, y | 60.8 ± 9.8 | 70.8 ± 7.3 | < 0.001 |
| Risk factors | |||
| Hypertension, n (%) | 47 (61.4) | 13 (50.0) | 0.324 |
| Dyslipidemia, n (%) | 39 (50.6) | 15 (57.7) | 0.534 |
| Diabetes mellitus, n (%) | 31 (40.3) | 10 (38.5) | 0.871 |
| Current smoker, n (%) | 23 (29.9) | 1 (3.8) | 0.007 |
| Medications before admission | |||
| Aspirin, n (%) | 63 (81.8) | 22 (84.6) | 0.745 |
| Statins, n (%) | 57 (74.0) | 21 (80.8) | 0.488 |
| β-Blockers, n (%) | 29 (37.7) | 10 (38.5) | 0.942 |
| ACE inhibitors, n (%) | 19 (24.7) | 7 (26.9) | 0.820 |
| Biochemistry data | |||
| TC, mg/dL | 151.6 ± 37.5 | 166.6 ± 37.5 | 0.082 |
| LDL-C, mg/dL | 79.4 ± 27.6 | 92.2 ± 27.0 | 0.043 |
| HDL-C, mg/dL | 40.2 ± 7.6 | 43.1 ± 12.6 | 0.164 |
| TG, mg/dL | 178.4 ± 167.7 | 149.9 ± 65.2 | 0.402 |
| HbA1c, % | 6.6 ± 1.3 | 6.9 ± 1.5 | 0.415 |
| hs-CRP, mg/L | 3.0 ± 2.8 | 1.6 ± 1.3 | 0.082 |
| Creatinine, mg/L | 0.9 ± 0.2 | 0.8 ± 0.2 | 0.018 |
| Fasting glucose, mg/L | 116.1 ± 41.8 | 139.1 ± 68.0 | 0.113 |
Abbreviations: HbA1c glycated hemoglobin, HDL-C high-density lipoprotein cholesterol, hs-CRP high-sensitivity C-reactive protein, IQR interquartile range, LDL-C low-density lipoprotein cholesterol, TC total cholesterol, TG triglycerides. Data are n (%) or mean ± SD